Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Coherus Bio (NQ: CHRS ) 2.035 -0.055 (-2.63%) Streaming Delayed Price Updated: 1:36 PM EDT, May 14, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,558,319 Open 2.040 Bid (Size) 2.030 (85) Ask (Size) 2.040 (40) Prev. Close 2.090 Today's Range 2.000 - 2.195 52wk Range 1.430 - 5.465 Shares Outstanding 114,725,740 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News CHRS Stock Earnings: Coherus BioSciences Misses EPS, Misses Revenue for Q1 2024 May 09, 2024 CHRS stock results show that Coherus BioSciences missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024. Via InvestorPlace Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update May 09, 2024 From Coherus BioSciences, Inc. Via GlobeNewswire Performance YTD -35.19% -35.19% 1 Month -7.50% -7.50% 3 Month -27.84% -27.84% 6 Month +18.31% +18.31% 1 Year -62.24% -62.24% More News Read More Coherus Announces Full Repayment of Pharmakon Advisors $75 Million Term Loan May 09, 2024 From Coherus BioSciences, Inc. Via GlobeNewswire Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination Evaluating LOQTORZI® (toripalimab-tpzi) with ENB Therapeutics' ENB-003 for the Treatment of Ovarian Cancer May 08, 2024 From Coherus BioSciences, Inc. Via GlobeNewswire Recap: Coherus BioSciences Q4 Earnings March 13, 2024 Via Benzinga Earnings Preview For Coherus BioSciences March 12, 2024 Via Benzinga Coherus to Report First Quarter 2024 Financial Results on May 9, 2024 May 01, 2024 From Coherus BioSciences, Inc. Via GlobeNewswire Coherus Announces Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting April 24, 2024 From Coherus BioSciences, Inc. Via GlobeNewswire Coherus Presents Preclinical Data for CHS-1000, a Novel Anti-ILT4 Antibody, at the 2024 AACR Annual Meeting April 08, 2024 From Coherus BioSciences, Inc. Via GlobeNewswire Why Coherus Biosciences Stock Tumbled on Thursday March 14, 2024 Via The Motley Fool Coherus BioSciences Reports Fourth Quarter, Full Year 2023 Financial Results and Provides Current Business Update March 13, 2024 From Coherus BioSciences, Inc. Via GlobeNewswire Coherus to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024 March 05, 2024 From Coherus BioSciences, Inc. Via GlobeNewswire Coherus Completes Divestiture of Ophthalmology Franchise March 04, 2024 From Coherus BioSciences, Inc. Via GlobeNewswire Earnings Scheduled For March 13, 2024 March 13, 2024 Via Benzinga Coherus BioSciences Announces New Employment Inducement Grants February 23, 2024 From Coherus BioSciences, Inc. Via GlobeNewswire Coherus Announces U.S. Launch of UDENYCA ONBODY™ a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv February 21, 2024 From Coherus BioSciences, Inc. Via GlobeNewswire Why Coherus BioSciences Stock Jumped Today February 06, 2024 Via The Motley Fool Coherus Amends Term Loan Agreement with Pharmakon Advisors, LP February 05, 2024 From Coherus BioSciences, Inc. Via GlobeNewswire Why Coherus BioSciences Stock Is Sinking Today January 23, 2024 Via The Motley Fool Why Coherus Biosciences Popped Today January 22, 2024 Via The Motley Fool Why CommScope Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session January 22, 2024 Via Benzinga Why Is Cancer Immunotherapy Focused-Coherus BioSciences Stock Trading Higher Today? January 22, 2024 Via Benzinga Why Is Cartesian Therapeutics (RNAC) Stock Down 5% Today? January 22, 2024 Via InvestorPlace Why Is B. Riley Financial (RILY) Stock Down 11% Today? January 22, 2024 Via InvestorPlace Topics Regulatory Compliance Exposures Legal Regulatory Why Is Coherus BioSciences (CHRS) Stock Up 17% Today? January 22, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
